Clinical trial

Tirzepatide Use in People With Obesity and Type 1 Diabetes

NCT07096908

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-07-31

PhasePHASE4

Study timeline

Study start (actual)2025-07-31Date precision: day

Registry last updated2026-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type1diabetesunresolved

Obesityunresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

PlaceboDRUG

Sponsors & collaborators

Dasman Diabetes Institutelead sponsor

University of Ulstercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07096908 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.